Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 18, 2019 10:51 ET | Source: Harrow Health, Inc.

Harrow Health, Inc to Locate Headquarters in Nashville, Tennessee

NASHVILLE, Tenn., June 18, 2019 (GLOBE NEWSWIRE) -- Tennessee Governor, Bill Lee, Department of Economic and Community Development Commissioner Bob Rolfe and Harrow Health, Inc (NASDAQ: HROW)...
May 29, 2019 07:00 ET | Source: Harrow Health, Inc.

Harrow Health Announces Renegotiated Debt Facility with SWK Holdings

SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it has amended its loan agreement with SWK Funding LLC and its partners. SWK Funding LLC is a...
May 09, 2019 16:01 ET | Source: Harrow Health, Inc.

Harrow Health Announces First Quarter 2019 Financial Results

SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the first quarter 2019. First Quarter 2019 and Other Recent Notable Highlights: ...
May 07, 2019 07:00 ET | Source: Harrow Health, Inc.

Harrow Health to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019

SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that its Chief Executive Officer, Mark L. Baum, will present an update on the company’s business at the...
May 02, 2019 07:00 ET | Source: Harrow Health, Inc.

Harrow Health to Announce First Quarter 2019 Financial Results on May 9, 2019

SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it will release first quarter 2019 financial results after the close of trading on Thursday, May 9,...
April 30, 2019 07:00 ET | Source: Harrow Health, Inc.

ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting

SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its participation at...
March 12, 2019 16:01 ET | Source: Harrow Health, Inc.

Harrow Health Announces Fourth Quarter 2018 Financial Results

SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the fourth quarter 2018. Fourth Quarter 2018 and Other Recent Notable Highlights: ...
March 04, 2019 07:00 ET | Source: Harrow Health, Inc.

Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019

SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending the 31st Annual ROTH Conference March 18-19, 2019 at The Ritz Carlton,...
February 28, 2019 07:00 ET | Source: Harrow Health, Inc.

Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019

SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it will release fourth quarter 2018 financial results after the close of trading on Tuesday, March 12,...
February 13, 2019 07:00 ET | Source: Harrow Health, Inc.; Melt Pharmaceuticals

Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations

SAN DIEGO and BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a specialty pharmaceutical company recently deconsolidated from Harrow Health, Inc. (NASDAQ: HROW), today...